Table 1. Relative Binding Affinitiesa of Aldoxime 1 and Ketoximes 2a–l for the Estrogen Receptors α and β.
ligand | hERα (%) | hERβ (%) | β/α ratio |
---|---|---|---|
estradiol | (100) | (100) | 1 |
1b | 0.064 ± 0.016 | 2.6 ± 0.6 | 41 |
2a | 0.54 ± 0.03 | 46 ± 14 | 85 |
2b | 3.0 ± 0.6 | 46 ± 9 | 15 |
2c | 0.16 ± 0.00 | 12 ± 3 | 75 |
2d | 1.9 ± 0.5 | 49 ± 5 | 26 |
2e | <0.005 | 0.011 ± 0.000 | >2 |
2f | <0.005 | <0.005 | |
2g | <0.005 | 0.015 ± 0.003 | >3 |
2h | <0.005 | 0.099 ± 0.030 | >20 |
2i | 0.10 ± 0.02 | 1.6 ± 0.1 | 16 |
2j | <0.005 | <0.005 | |
2k | 0.033 ± 0.008 | 1.1 ± 0.1 | 33 |
2l | <0.005 | <0.005 | |
2m | 0.036 ± 0.006 | 0.76 ± 0.10 | 21 |
Determined by a competitive radiometric binding assay with [3H]estradiol. Preparations of purified, full-length human ERα and ERβ (PanVera) were used; see Experimental Section. Values are reported as the mean ± the range or SD of two or more independent experiments. The Kd of estradiol for ERα is 0.2 nM and for ERβ is 0.5 nM. Ki values for the new compounds can be readily calculated by using the formula Ki = (Kd[estradiol]/RBA) × 100.
See ref (13b).